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RAW264.7 macrophages and human peripheral blood mononuclear cells were treated with LPS to
determine the expression of KLF4 and release of IL-1b. A full-length cDNA or short interference
RNA of KLF4 was transfected into RAW264.7 macrophages; the expression and release of IL-1b were
analyzed. The transcription and DNA binding activities of KLF4 to the IL-1b promoter were detected
further. The results showed LPS treatment resulted in the increase of KLF4 level and IL-1b release;
KLF4 overexpression decreased the expression of IL-1b, while KLF4 inhibition increased the expres-
sion of IL-1b; overexpression of KLF4 promoted the DNA binding activity of KLF4 to the IL-1b pro-
moter and attenuated the transcription of IL-1b promoter, indicating an important role of KLF4 in
regulating expression of IL-1b.
 2012 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Krüppel-like factors (KLFs) are zinc ﬁnger-containing transcrip-
tion factors that exhibit homology to Krüppel from Drosophila [1].
Multiple members in KLF family are involved in inﬂammatory re-
sponse [2,3]. KLF4 (gut Krüppel-like factor, GKLF) was ﬁrst identi-
ﬁed in the epithelial lining of the gut and skin, and subsequent
studies have shown that KLF4 plays a role in the regulation of cel-
lular growth and differentiation in these tissues [4]. Recently, KLF4
has been shown to be induced by IFN-c, LPS, and TNF-a in macro-
phages, and interacts with the NF-jB family member p65 to coop-
eratively induce the iNOS promoter [5,6]; the previous studies in
our laboratory also found that KLF4 could regulate the expression
and secretion of interleukin-10 (IL-10) and high mobility group
box 1 (HMGB1) in response to LPS [7,8]. As for the regulation ef-
fects of KLF4 on the inﬂammatory mediators, we still speculate
that KLF4 also can regulate some other inﬂammatory mediators,
which needs further study.chemical Societies. Published by E
f Pathophysiology, Xiangya
ngya Road, Changsha, Hunan
55019.
xianzhongxiao@xysm.net (X.
er.Interleukin 1 beta (IL-1b) is part of the interleukin-1 family and
is a pro-inﬂammatory cytokine. It is a soluble protein that is se-
creted by monocytes, macrophages, and accessory cells, which
are involved in the activation of T-lymphocytes and B-lymphocytes
[9]. Monocytes are one type of white blood cells that are precursors
to macrophages, which are phagocytes that ingest antigens. Both
monocytes and macrophages activate the T-lymphocytes (T-cells)
and B-lymphocytes which are cells that defend against viral infec-
tion and intracellular protozoan parasites [9,10]. Interleukin-1 is
released early in an immune response by monocytes or macro-
phages and mediates the lymphocyte response to antigens or mit-
ogens. Among interleukin-1 family, interleukin-1 beta can be
activated by a second signaling mechanism involving the inﬂam-
masome and caspase 1. The rate-limiting step in the release of
IL-1b appears to be the translation of the mRNA into the IL-1b pre-
cursor [10]. In circulating human blood monocytes, caspase-1 is
present in an already active state; when the monocyte is stimu-
lated to synthesize the IL-1b precursor, cleavage of the precursor
takes place and mature IL-1b is secreted over several hours [10].
IL-1b, also called endogenous pyrogen, is highly regulated both
transcriptionally and post-transcriptionally; it can be induced
transcriptionally through a number of pathways including through
Toll-like receptors (TLRs), which may be activated by microbial
pathogens, or by cytokines including TNF-a (tumor necrosis
factor-a) and IL-1b itself. These pathways lead to activation oflsevier B.V. All rights reserved.
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binding protein b, PU.1, and interferon regulatory factor 4 [9–11].
By using Matinspector Professional program at www.genomatix.de
and Transcription Element Search System (TESS) at www.cbil.u-
penn.edu, we found that several inﬂammatory mediator genes
including IL-1b contain putative KLF4 binding sites in their pro-
moters. However, the direct effect of KLF4 on the expression of
IL-1b remains unknown.
In this report, the expressions of KLF4 and IL-1b in response to
LPS were determined in RAW264.7 macrophages and human
peripheral blood mononuclear cells (PBMCs). In addition, the ef-
fects of KLF4 on the expression and release of IL-1b, and the mech-
anism of how KLF4 regulates the IL-1b gene were also investigated.2. Materials and methods
2.1. Cell culture and reagent
.Murine RAW264.7macrophages were routinely grown in RPMI-
1640 medium (Gibco) supplemented with 10% fetal calf serum at
37 C and 5% CO2. Human PBMCs were isolated from donor blood
by Ficoll density gradient centrifugation and cultured in RPMI-
1640 medium with 10% heat-inactivated human serum and 2 mM
glutamine overnight. Non-adherent cells were subsequently re-
moved, and adherent monocyte-enriched cultures were stimulated
for the further treatment. Informed consent was obtained from do-
nors (n = 3). ATP and LPS (Escherichia coli 0111:B4) was purchased
from Sigma.
2.2. RNA extraction and real-time PCR
Total RNA was isolated using Trizol Reagent (Invitrogen) in
accordance with the manufacturer’s protocol. After extraction,
5 lg of total RNA was then used as a template to synthesize the
complimentary cDNA using First Strand Synthesis Kit (Invitrogen).
The cDNA from this synthesis was then used in quantitative real-
time PCR analysis with the TaqMan system (ABI-Prism 7700
Sequence Detection System, Applied Biosystems) using SYBR Green
dye. The following primer pairs of mouse origin were used [12,13]:
KLF4 (286 bp), 50-TGC CAG ACC AGA TGC AGT CAC-30 (Forward)
and 50-GTA GTG CCT GGT CAG TTC ATC-30 (Reverse); IL-1b
(229 bp), 50-GCC CAT CCT CTG TGA CTC AT-30 (Forward) and 50-
AGG CCA CAG GTA TTT TGT CG-30 (Reverse); Cyclophilin A
(132 bp), 50-CAG ACG CCA CTG TCG CTT T-30 (Forward) and 50-
TGT CTT TGG AAC TTT GTC GCA A-30 (Reverse). RT-PCR data were
normalized by measuring average cycle threshold (Ct) ratios be-
tween candidate genes and the control gene, Cyclophilin A. The for-
mula 2Ct(Candidate)/2Ct(Control) was used to calculate normalized
ratios.
2.3. Western blot analysis
After various treatments, proteins in the whole-cell lysate were
resolved on 10% SDS–PAGE and then transferred onto PVDF mem-
branes (Schleicher & Schuell). The membranes were blocked over-
night in phosphate-buffered saline containing 10% non-fat dry milk
and 0.5% Tween-20, and incubated with primary antibodies for 2 h.
Horseradish peroxidase-conjugated anti-rabbit or anti-mouse IgG
was used as the secondary antibody. The immunoreactive bands
were visualized using DAB (Boster Biological Technology, China).
Anti-GAPDH was used to normalize for equal amounts of proteins
and calculate the relative induction ratio. The following antibodies
were used: Rabbit anti-KLF4 polyclonal antibody (Santa Cruz Bio-
technology); mouse anti-glyceraldehyde-3-phosphate dehydroge-
nase (GAPDH) monoclonal antibody (Sigma); Rabbit anti-KLF2polyclonal antibody (Abcam); HRP-conjugated anti-mouse and
anti-rabbit IgG (Boster Biological Technology, China).
2.4. Generation of constructs
Oligonucleotide primers were designed to amplify the coding
sequence of mouse KLF4 cDNA, yielding a 1.5 kb product. The oli-
gonucleotide primers are as follows: KLF4, 50-AGT TGG ACC CAG
TAT ACA TTC CGC CAC AGC AGC CT-30 (Forward) and 50-TTA AAA
GTG CCT CTT CAT GTG TAA GGC AAG GTG GT-30 (Reverse). The
PCR product was electrophoresed onto 0.9% agarose and 1.5 kb
fragment was puriﬁed with the puriﬁcation system (Qiagen). The
fragment was then inserted into the pcDNA3.1 vector (Strategene)
and sequenced commercially (Invitrogen).
2.5. Lipofectamine-mediated gene transfection
Transfection of RAW264.7 macrophages was carried out accord-
ing the manufacturer’s instructions (LIPOFECTAMINE 2000™, Invit-
rogen), as described previously [14]. Brieﬂy, about 5  105 cells per
bottle containing 5 ml appropriate complete growth medium were
seeded, and incubated at 37 C with 5% CO2 until the cells were
70–80% conﬂuent (24 h). After the cells were rinsed with serum
free and antibiotics-free medium, the cells were transfected sepa-
rately with pcDNA3.1-KLF4 10 lg/lipofectamine 20 ll (experimen-
tal group), pcDNA3.1 10 lg/lipofectamine 20 ll (vector control),
followed by incubation at 37 C in a CO2 incubator for 6 h. The
medium was then replaced with DMEM culture medium contain-
ing 10% FBS. After 48 h recovery, G418 (Gibco/BRL) was added at
1000 lg/ml for 20 days, when colonies were picked and expanded
under G418 selection.
2.6. RNA interference
The short interference (si)RNAs against mouse KLF4 (sc-35479)
and its control were purchased from Santa Cruz Biotechnology.
Transfection of KLF4 siRNA was performed using siPORT Amine
(Ambion Inc.) according to the siRNA transfection protocol [14].
To ensure the knock down of KLF4 protein production, Western
blot was performed with KLF4 antibody.
2.7. Cytokines measurement
Cells were treated with LPS at the time points and doses indi-
cated. IL-1b was quantiﬁed in conditioned medium using en-
zyme-linked immunosorbent assay (ELISA) kit (Boster Biological
Technology, China) and expressed in picograms per milliliter.
Absorbance was determined at 450 nm using a microplate reader
(Bio-Tek Instruments).
2.8. Nuclear extract preparation and electrophoretic
mobility shift assays
After the treatment, KLF4-overexpressed cells and the vector
controls of RAW264.7 macrophages were harvested and washed
twice with cold PBS. Brieﬂy, the cell pellet was resuspended in
400 ll cold buffer A (10 mM HEPES, pH 7.9, 10 mM KCl, 0.1 mM
EDTA, 0.1 mM EGTA, 1 mM DTT, 0.5 mM PMSF). The cells were al-
lowed to swell on ice for 15 min, then 25 ll of a 10% solution of
Nonidet P-40 (NP-40) was added, and the tube was vortexed vigor-
ously for 10 s. The homogenate was centrifuged at 10,000g for 30 s,
and the nuclear pellet was resuspended in 50 ll ice-cold buffer B
(20 mM HEPES, pH 7.9, 0.4 M NaCl, 1 mM EDTA, 1 mM EGTA,
1 mM DTT, 1 mM PMSF). After vigorously rocking at 4 C for
15 min on a shaking platform, the nuclear extract was centrifuged
at 10,000g for 5 min in a microfuge at 4 C, and the supernatant
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ent fractions was determined by a Bradford method. Electropho-
retic mobility shift assays were performed using nuclear extracts
from RAW264.7 macrophages according to the instructions of
Chemiluminescent Nucleic Acid Detection Module (Pierce). Super-
shift antibody for KLF4 was incubated with nuclear extracts of
KLF4-overexpressed RAW264.7 macrophages for 1 h at 4 C prior
to adding the HRP-labeled oligonucleotide. DNA probes were also
generated according to the KLF site at positions 27 to 14 bp of
the mouse IL-1b promoter as double-stranded, HRP-labeled oligo-
nucleotides corresponding to the wild-type sequences (50-AA-
CAAGGGAGGGAA-30) and mutant sequence [15] for the position
of 27 to 14 bp (50-ACCATGTGATGGAA-30).
2.9. Chromatin immunoprecipitation (ChIP) assays
ChIP assays were performed according to the provider’s proto-
col (Upstate Biotechnology), as described previously [14]. In brief,
cells were grown to 80–90% conﬂuence. After cross-linking for
10 min with 1% formaldehyde in serum-free medium, phos-
phate–glycine buffer was added to a ﬁnal concentration of
0.125 m, and cells were washed twice with ice-cold PBS. The chro-
matin lysate was sonicated on ice to an average DNA length of
600 bp. Chromatin was precleared with blocked Sepharose A, and
ChIP assays were performed with either the KLF4 antibody or the
KLF2 antibody (Santa Cruz Biotechnology) as the speciﬁc control,
and control IgG as the negative control. The ﬁnal PCR step was per-
formed to amplify the fragment spanning the nucleotides from
100 to +10 of the IL-1b promoter sequence using the primers
(Forward: 50-CAG TTT TGT TGT GAA ATC AG-30; Reverse: 50-CAG
GGT TTG TTG TCC AAC TT-30). Reaction products were analyzed
on a 1.5% agarose–Tris–borate EDTA gel stained with ethidium bro-
mide and visualized under UV light.
2.10. Luciferase reporter gene assays
The assay was performed according to the instruction of Dual
Luciferase Reporter System (Promega), as described previously
[14]. Generation of mouse IL-1b promoter construct (500 to
+10) was performed by PCR using mouse genomic DNA as the tem-
plate and cloned into pGL3-Basic, and authenticity was veriﬁed by
sequencing (data not shown). For luciferase reporter assay, expo-
nentially growing RAW264.7 cells were seeded in 24-well culture
dishes. Transfections were done as described above. All transfec-
tions were performed in triplicate from at least three independent
experiments. Each transfection experiment contained 500 ng of
pGL3-IL1b promoter reporter construct with 20 ng of pRL-null vec-
tor (Promega) as an internal transfection control.
2.11. Statistical analysis
Data in the ﬁgures and text were expressed as means ± S.E.M.
Each experiment was performed at least three times, and statistical
analysis was performed using two-tailed Student’s t test. Other-
wise representative data were shown. P < 0.05 was considered
signiﬁcant.3. Results
3.1. LPS induces the expression of KLF4 and IL-1b in PBMCs
and RAW264.7 macrophages
It has been demonstrated that KLF4 is induced after 1 h of stim-
ulation with IFN-c, TNF-a, and LPS in J774a or THP-1 cells [5]. We
also found that KLF4 was up-regulated sustainably in response toLPS at a dose- and time-dependent manner in RAW264.7 macro-
phages [16]. In this report, we showed that the KLF4 expression
in peripheral blood mononuclear cells (PBMCs) treated with LPS
(500 ng/ml) for various periods of time. As shown in Fig. 1A and
B, LPS treatment led to a sustainable increase in the mRNA levels
of KLF4 from 4 to 24 h. Fig. 1C was a dose–response study in PBMCs
treated with LPS for 4 h then. As shown, there was a dose-depen-
dent increase in the KLF4 levels.
To investigate the expression of IL-1b, RAW264.7 macrophages
and PBMCs were treated with LPS (1000 ng/ml) and the levels of IL-
1b peptide were detected by ELISA. Fig. 1D showed that IL-1b was
increased at 12 h after LPS stimulation. The increased levels of KLF4
and IL-1b suggested a potential relationship between the genes.
3.2. KLF4 inﬂuences the expression of IL-1b in RAW264.7 macrophages
By using bioinformatics analysis, we found the putative KLF4
binding site in promoter sequence of IL-1b. Because KLF4 was in-
duced by LPS and signiﬁcantly increased in the early phase, we
considered the possibility that this transcription factor may inﬂu-
ence the expression of IL-1b, an important early proinﬂammatory
gene. We overexpressed KLF4 in RAW264.7 macrophages using
pcDNA3.1-KLF4 construct (Fig. 2A), which the cell viability was
not reduced by the transfection signiﬁcantly (by MTT assay, data
not shown). As demonstrated in Fig. 2B, overexpression of KLF4
led to a decreased expression of IL-1b mRNA. In response to the
LPS treatment, the level of IL-1b mRNA in KLF4-overexpressed
group was still much lower than the vector control group.
We further investigated the effect of KLF4 overexpression on
the release of the IL-1b peptide by ELISA. Fig. 2C showed the de-
creased basal level of IL-1b peptide upon KLF4 overexpression.
LPS stimulation signiﬁcantly increased IL-1b in the vector control
group; while the LPS-induced level of IL-1b was decreased upon
KLF4 overexpression and was still lower than that observed in
the corresponding vector control group. Since the extracellular
ATP could induce the processing and release of IL-1b physiologi-
cally, we also observed the release change of IL-1b in the presence
of ATP upon overexpression of KLF4. As shown in Fig. 2D, the re-
lease of IL-1b was not further increased obviously upon ATP treat-
ment after KLF4 overexpression.
In order to observe the effect of KLF4 inhibition on the release of
IL-1b peptide, we transfected short interference (si)RNAs against
mouse KLF4 into RAW264.7 macrophages. Expression of KLF4
was detected by real-time PCR and Western blot for identiﬁcation
of basal KLF4 inhibition, as well as during LPS stimulation period
(Fig. 2E and F). After the basal expression of KLF4 was inhibited,
the mRNA levels and release of IL-1bwere determined by real-time
PCR and ELISA, respectively. As shown by Fig. 2G and H, after KLF4
inhibition, the LPS-induced mRNA levels and release of IL-1b were
further induced compared to the control group.
3.3. KLF4 regulates IL-1b promoter in RAW264.7 macrophages
KLFs are transcription factors that bind DNA and thereby regu-
late the expression of various target genes. To determine whether
the potential KLF4 binding site on the IL-1b promoter is capable of
binding KLF4, we performed EMSA. Fig. 3A and B showed that the
transfection of KLF4 promoted the binding of HRP-labeled probe de-
signed according to the IL-1bpromoter (site at27 to14 bp) to the
KLF4 protein in the nuclear extract of RAW264.7 macrophages, and
LPS stimulation induced the further binding of DNA to KLF4. Speci-
ﬁcity was veriﬁed by mutant oligonucleotides, which failed to bind
to KLF4, and by antibody competition. In the group plus KLF4 anti-
body, since the molecular size of KLF4 antibody complex binding
with DNA was too high to shift, there was no band in the KLF4 anti-
body lane.
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Fig. 1. Expression of KLF4 and IL-1b in LPS-stimulated PBMCs or RAW264.7 macrophages. (A) PBMCs and RAW 264.7 macrophages were stimulated with LPS at indicated
dose for various periods of time, and mRNA levels of KLF4 in various periods of time were determined by real-time PCR. (B) PBMCs were stimulated with LPS at indicated dose
for various periods of time and protein levels of KLF4 in various periods of time were determined by Western blot. (C) Proteins of KLF4 in LPS-stimulated PBMCs at indicated
doses for 4 h were determined by Western blot. (D) LPS (1000 ng/ml) induced levels of IL-1b in RAW264.7 macrophages and PBMCs for indicated periods of time were
determined by ELISA. The relative values of all results were determined and expressed as mean ± S.E.M. of three experiments induplicate. ⁄, versus control group (Ctrl),
P < 0.05.
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the IL-1b promoter. Fig. 3C showed the PCR product after the
immunoprecipitation of the cross-linked chromatin with the
KLF4 antibody. As a speciﬁc control, puriﬁed rabbit IgG performed
in parallel did not yield detectable PCR product. Collectively, these
data support that KLF4 binds to the IL-1b promoter, which spans
the sequence from 100 to +10 in the IL-1b promoter sequence.
In order to understand how KLF4 can regulate IL-1b, we as-
sessed its effect on IL-1b promoter activity. A strong trans-inhibi-
tion effect of KLF4 on the IL-1b promoter was shown in Fig. 3D,
which was further conﬁrmed by another transcription factor,
KLF2, as a control.
4. Discussion and conclusions
Inﬂammation is the complex biological response to harmful
stimuli such as pathogens, damaged cells or irritants. Various cyto-
kines are involved in the process of inﬂammation, and the cytokine
expression is regulated by many transcriptional factors [17]. KLF4
is a zinc ﬁnger-containing transcription factor, and has been widely
investigated in both normal development and carcinogenesis
[18,19]. Furthermore, KLF4 has also been identiﬁed as a mediator
of the proinﬂammatory response. KLF4 mRNA is markedly induced
after only 1 h of stimulation with IFN-c, LPS and TNF-a in J774a or
THP-1 cells, as well as hydrogen peroxide (H2O2) and heat shock
response [20]. Our previous study indicated that KLF4 mRNA wasup-regulated after 2 h of stimulation with LPS in adult mice lung
tissue, and was still up-regulated more than 10-fold at 20 h after
LPS stimulation [21], more data in our laboratory showed that
KLF4 could be induced by LPS in RAW264.7 macrophages in dose-
and time-dependent manners [7], as well as in PBMCs as shown in
this paper, which suggested the potential role of KLF4 in LPS-in-
duced inﬂammation.
Together with TNFa, IL-1a and IL-1b are deﬁned as ‘‘alarm cyto-
kines’’ that are secreted by macrophages and initiate inﬂammation
[22]. IL-1a and IL-1b can initiate the inﬂammation, but more impor-
tantly they can induce the expression of further pro-inﬂammatory
genes. Of major importance are cyclooxygenase type 2 (COX-2),
inducible nitric oxide synthase (iNOS), IL-6 and other chemokines/
cytokines [23]. By bioinformatics analysis, we found that a part of
inﬂammatory mediator genes including IL-1b contain putative
KLF4 binding elements in their promoters. In the further experi-
ments of KLF4 overexpression and inhibition in RAW264.7 macro-
phages, we found the basal decrease of IL-1b upon KLF4
overexpression, and the subsequent expression changes of IL-1b in-
duced by LPS after KLF4 overexpression or inhibition. After KLF4
overexpression, the basal expression of IL-1b decreased signiﬁcantly
and it was still much lower than that in the control group induced
by LPS; while after KLF4 inhibition, the LPS-induced release of IL-1b
was further induced compared to the control oligo group. Although
the induction of KLF4 could down-regulate the expression of IL-1b,
while the expression of IL-1b could be regulated by other signaling
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Fig. 2. Effect of KLF4 on expression of IL-1b in RAW264.7 macrophages. (A) RAW264.7 macrophages were transfected with pcDNA3.1-KLF4 and the expression level of KLF4
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838 J. Liu et al. / FEBS Letters 586 (2012) 834–840pathways, and then the down-regulation of KLF4 on IL-1b was not
complete, which the total level of IL-1b was increased slightly upon
LPS stimulation. The expression and secretion of IL-1b down-regu-
lated by KLF4 in this study suggests at least one of pathways for
IL-1b regulation. Meanwhile, it has been demonstrated that extra-
cellular ATP can induce rapid processing and extensive release of
bioactive IL-1 cytokines [24]; here, we also observed that the release
of IL-1b was not further increased obviously upon ATP treatment
after KLF4 overexpression. This might be resulted from the down-
regulation of IL-1b by KLF4, and furthermore, the inhibitory effect
of KLF4 on activity of NF-kappa B [5,25], which inﬂuence the further
IL-1b change in response to ATP; further experiments are needed in
the future investigations.As a transcriptional factor, many target genes of KLF4 have
been demonstrated, including CYP1A1, ornithine decarboxylase,
histidine decarboxylase, cyclin D1 [26], interleukin 10, and
HMGB1 [7,8]. KLF4 regulates the target genes by binding to the
potential KLF4 binding elements in their promoters. By bioinfor-
matics methods, we found that the promoter of IL-1b contained
one potential KLF4 binding elements, 27 to 14 bp. We have
shown that KLF4 decreased transcription of the IL-1b gene by
binding to the promoter sequence between 27 and 14 bp up-
stream of the initiation site. Our studies provide further elucida-
tion of the molecular mechanism by which KLF4 exerts its
regulatory effects on the expression of IL-1b. LPS and KLF4 over-
expression promoted the binding of KLF4 to its binding element
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Fig. 3. DNA binding activity and transcription activity of KLF4 to the KLF binding element of IL-1b promoter in RAW264.7 macrophages. (A) KLF4 bound to the KLF binding
element in the region of 27 to 14 bp in IL-1b promoter. (B) KLF4 overexpression and LPS promoted the binding of KLF4 to the corresponding probes containing KLF4
binding element. pcDNA3.1: the vector control group: pcDNA3.1-KLF4: KLF4 overexpression group; Cold probe: competition with clod probe (200-fold molar excess
concentration); Mutant probe: competition with mutant cold probe (200-fold molar excess concentration); KLF4 Ab: Supershift group by KLF4 antibody. LPS: cells stimulated
by LPS (500 ng/ml) for 4 h. (C) ChIP assay was used to detect the binding of KLF4 to the IL-1b promoter. The cross-linked protein-DNA complexes were immunoprecipitated
with the anti-KLF4 antibody (lanes 2, 4 and 6), or with a puriﬁed rabbit IgG as a negative control (lane 7), or with the anti-KLF2 antibody as a speciﬁc control (lane 8). PCR of
the input (sample representing PCR ampliﬁcation from a 1:25 dilution of total input chromatin from the ChIP experiment) is shown in lane 3. The PCR control represents the
PCR ampliﬁcation in the absence of DNA (lane 1). Lane M, Marker; laneWater control, negative control; lane LPS, LPS treatment (1000 ng/ml for 12 h) plus KLF4 antibody; lane
Input, positive control; lane KLF4 ab, untreated cells plus KLF4 antibody; lane IgG control, negative control for KLF4 antibody; lane KLF2 ab, untreated cells plus KLF2
antibody. (D) RAW264.7 macrophages were co-transfected transiently with a corresponding expression plasmid (500 ng) and a reporter driven by IL-1b promoter (500 ng).
The luciferase activity was detected using Dual Luciferase Reporter System. All transfections were performed at least three times in triplicate. Cells were treated with LPS
(1000 ng/ml) for 24 h. KLF4 and KLF2 expressions were determined by Western blot. Neo: the cell group transfected with pcDNA3.1; KLF4: the cell group transfected with
pcDNA3.1-KLF4; Mut: the cell group transfected with pGL3-mutIL-1b; KLF2: the cell group transfected with pcDNA3.1-KLF2. ⁄, P < 0.05.
J. Liu et al. / FEBS Letters 586 (2012) 834–840 839in IL-1b promoter. KLF4 may allow for induction of some promot-
ers (e.g. iNOS) but inhibition of Smad3-responsive promoters (e.g.
PAI-I) by the interaction with the C terminus of p300 [5]. It can be
assumed that KLF4 interacts with other potential proteins like
p300 to cooperatively regulate the IL-1b promoter, which needs
to be demonstrated further.IL-1b activity is tightly controlled and requires the conversion
of the primary transcript, the inactive IL-1b precursor, to the ac-
tive cytokine by limited proteolysis. Therefore, blocking IL-1b re-
solves inﬂammation regardless of how the cytokine is released
from the cell or how the precursor is cleaved. Endogenous stim-
ulants such as oxidized fatty acids and lipoproteins, high glucose
840 J. Liu et al. / FEBS Letters 586 (2012) 834–840concentrations, uric acid crystals, activated complement, contents
of necrotic cells, and cytokines, particularly IL-1 itself, induce the
synthesis of the inactive IL-1b precursor, which awaits processing
to the active form. Although bursts of IL-1b precipitate acute at-
tacks of systemic or local inﬂammation, IL-1b also contributes
to several chronic diseases, such as atherosclerosis, type 2 diabe-
tes, osteoarthritis and smoldering myeloma [27,28]. KLF4 regula-
tion on IL-1b should be a potential mechanism for elucidation of
IL-1b function.
In summary, our study demonstrates the induction of KLF4 by
LPS in PBMCs and macrophages, further determines that KLF4 is a
potential inﬂammatory transcriptional factor playing a critical role
in the regulation of the expression of IL-1b by its interaction with
the KLF element on its promoter. Discovering the exact functions
of KLF4 in inﬂammation is clinically signiﬁcant for the pathogenesis
and therapies of inﬂammatory diseases such as endotoxemia, as
well as the ﬁnding of other genes involved in KLF4 pathways.
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